Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

Healthcare
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.


TSXV:RX - Post by User

Biosyent Inc > Decent dividend
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2142)
•••
Comment by lscfaon Oct 16, 2022 12:51pm
147 Views
Post# 35027743

RE:RE:RE:RE:RE:Decent dividend

RE:RE:RE:RE:RE:Decent dividend

BioSyent Inc. ( RX )  
Listed Company    
 
  MARKET CAPITALIZATION
 Show Market Cap based on date range selected below
 

Effective Date Expiry Date Authorized Shares Issued Escrow Last Price Market Cap** Float Quoted Market Value*** Description  
05/Oct/2022   Unlimited 12,404,961 0 6.750 83,733,487 83,733,486.750 Computershare - ncib  
13/Sep/2022  04/Oct/2022 Unlimited 12,431,561 0 8.150 101,317,222 101,317,222.150 computershare  
05/Aug/2022  12/Sep/2022 Unlimited 12,509,861 0 7.910 98,953,001 98,953,000.510 computershare  
08/Jul/2022  04/Aug/2022 Unlimited 12,585,661 0 8.100 101,943,854 101,943,854.100 computershare  
10/Jun/2022  07/Jul/2022 Unlimited 12,614,661 0 8.010 101,043,435 101,043,434.610 Computershare - ncib  
03/Jun/2022  09/Jun/2022 Unlimited 12,616,561 0 8.010 101,058,654 101,058,653.610 computershare  
17/May/2022  02/Jun/2022 Unlimited 12,634,161 0 8.850 111,812,325 111,812,324.850 Computershare - ncib  
12/Apr/2022  16/May/2022 Unlimited 12,639,361 0 9.830 124,244,919 124,244,918.630 computershare  
30/Mar/2022  11/Apr/2022 Unlimited 12,634,113

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities